Daniel W. Foster

A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.

Julie McGarry, G P Mannaerts, Daniel W. Foster · Journal of Clinical Investigation · 1977 · 734 citations · Full text

Octanoic Acids, Fatty Liver Disease, Oxidative Stress +17

Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA.

Julie McGarry, G.F. Leatherman, Daniel W. Foster · Journal of Biological Chemistry · 1978 · 598 citations · Full text

Metabolic Syndrome, Carnitine Palmitoyltransferase, Biochemistry +9

Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat

Julie McGarry, Stanley E. Mills, Carlin S. Long et al. · Biochemical Journal · 1983 · 551 citations · Full text

Non-hepatic Tissues, Experimental Pharmacology, Malonyl-coa Sensitivity +19

An improved and simplified radioisotopic assay for the determination of free and esterified carnitine

Julie McGarry, Daniel W. Foster · Journal of Lipid Research · 1976 · 524 citations · Full text

Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway?

Christopher B. Newgard, LJ Hirsch, Daniel W. Foster et al. · Journal of Biological Chemistry · 1983 · 312 citations · Full text

Glycobiology, Hepatotoxicity, Intermediary Metabolism +21